NO953426L - Varianter av gallesalt-stimulert lipase, DNA molekyler som koder for disse og transgene ikke-humane pattedyr - Google Patents

Varianter av gallesalt-stimulert lipase, DNA molekyler som koder for disse og transgene ikke-humane pattedyr

Info

Publication number
NO953426L
NO953426L NO953426A NO953426A NO953426L NO 953426 L NO953426 L NO 953426L NO 953426 A NO953426 A NO 953426A NO 953426 A NO953426 A NO 953426A NO 953426 L NO953426 L NO 953426L
Authority
NO
Norway
Prior art keywords
bssl
bile salt
variants
dna molecules
stimulated lipase
Prior art date
Application number
NO953426A
Other languages
English (en)
Norwegian (no)
Other versions
NO953426D0 (no
Inventor
Lars Blackberg
Michael Edlund
Lennart Hansson
Olle Hernell
Lennart Lundberg
Mats Stromqvist
Jan Tornell
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9300686A external-priority patent/SE9300686D0/xx
Priority claimed from SE9300722A external-priority patent/SE9300722D0/xx
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO953426D0 publication Critical patent/NO953426D0/no
Publication of NO953426L publication Critical patent/NO953426L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/01—Animal expressing industrially exogenous proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/20043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Environmental Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Diabetes (AREA)
  • Animal Husbandry (AREA)
  • Virology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
NO953426A 1993-03-01 1995-08-31 Varianter av gallesalt-stimulert lipase, DNA molekyler som koder for disse og transgene ikke-humane pattedyr NO953426L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9300686A SE9300686D0 (sv) 1993-03-01 1993-03-01 Novel polypeptides
SE9300722A SE9300722D0 (sv) 1993-03-04 1993-03-04 Novel polypeptides ii
PCT/SE1994/000160 WO1994020610A1 (en) 1993-03-01 1994-02-25 Variants of bile salt-stimulated lipase, dna molecules encoding them, and transgenic non-human mammals

Publications (2)

Publication Number Publication Date
NO953426D0 NO953426D0 (no) 1995-08-31
NO953426L true NO953426L (no) 1995-08-31

Family

ID=26661673

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953426A NO953426L (no) 1993-03-01 1995-08-31 Varianter av gallesalt-stimulert lipase, DNA molekyler som koder for disse og transgene ikke-humane pattedyr

Country Status (28)

Country Link
US (2) US5827683A (is)
EP (1) EP0687296B1 (is)
JP (1) JP3837444B2 (is)
KR (2) KR100357016B1 (is)
CN (2) CN1071790C (is)
AT (1) ATE317429T1 (is)
AU (1) AU675701B2 (is)
BR (1) BR9406376A (is)
CA (1) CA2156083C (is)
CZ (1) CZ290927B6 (is)
DE (1) DE69434622T2 (is)
DK (1) DK0687296T3 (is)
EE (1) EE9400458A (is)
ES (1) ES2258262T3 (is)
FI (1) FI954082A0 (is)
HU (1) HU221119B1 (is)
IL (2) IL144015A (is)
IS (1) IS4130A (is)
NO (1) NO953426L (is)
NZ (1) NZ262529A (is)
PL (1) PL184960B1 (is)
PT (1) PT687296E (is)
RU (1) RU2219239C2 (is)
SG (1) SG52597A1 (is)
SK (1) SK285420B6 (is)
TW (1) TW387013B (is)
UA (1) UA48109C2 (is)
WO (1) WO1994020610A1 (is)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0795011A1 (en) * 1994-12-01 1997-09-17 Oklahoma Medical Research Foundation Method and compositions for reducing cholesterol absorption
US5681819A (en) * 1994-12-01 1997-10-28 Oklahoma Medical Research Foundation Method and compositions for reducing cholesterol absorption
US5696087A (en) * 1994-12-01 1997-12-09 Oklahoma Medical Research Foundation Method and compositions for reducing cholesterol absorption
US5821226A (en) * 1994-12-01 1998-10-13 Oklahoma Medical Research Foundation BAL C-tail drug delivery molecules
FR2733249B1 (fr) 1995-04-20 1997-06-06 Biocem Lipase gastrique de chien recombinante et polypeptides derives produits par les plantes, leurs procedes d'obtention et leurs utilisations
SE9501939D0 (sv) * 1995-05-24 1995-05-24 Astra Ab DNA molecules for expression of polypeptides
US6342218B1 (en) 1997-02-14 2002-01-29 Oklahoma Medical Research Foundation Method for treatment of SLE
SE9801424D0 (sv) 1998-04-22 1998-04-22 Astra Ab Expression methods
AU2001255469A1 (en) * 2000-04-21 2001-11-07 Monsanto Technology Llc Purification of ace inhibiting polypeptides containing vpp from milk
US7557193B2 (en) 2004-03-31 2009-07-07 Universite De La Mediterranee Glycopeptides derived from pancreatic structures, antibodies and applications thereof in diagnostics and therapeutics
FR2868424B1 (fr) * 2004-03-31 2008-04-11 Univ Aix Marseille Ii Glycopeptides derives de structures pancreatiques, anticorps et leurs applications en diagnostic et therapeutique
CN100343391C (zh) * 2004-12-31 2007-10-17 中国农业大学 卵巢注射法制备转基因动物
EP2039764A1 (en) * 2007-09-19 2009-03-25 Pevion Biotech AG Truncated secretory aspartyl proteinase 2
CA2812852A1 (en) 2010-10-21 2012-04-26 Swedish Orphan Biovitrum Ab (Publ) Method to increase the absorption of unsaturated fatty acids by human infants
DK2629790T3 (en) * 2010-10-21 2016-10-24 Swedish Orphan Biovitrum Ab (Publ) Approach to increase growth rate of human babies
FR2966734B1 (fr) 2010-10-29 2014-07-18 Max Rombi Composition comprenant au moins une enzyme proteolytique pour son utilisation pour empecher la synthese des triglycerides
AU2012256449B2 (en) * 2011-05-18 2015-04-09 Swedish Orphan Biovitrum Ab (Publ) Low pH protein purification process
CN103088000A (zh) * 2012-03-23 2013-05-08 北京济福霖生物技术有限公司 在哺乳动物乳腺中过表达胆盐激活脂酶的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4944944A (en) * 1987-11-19 1990-07-31 Oklahoma Medical Research Foundation Dietary compositions and methods using bile salt-activated lipase
US5200183A (en) * 1987-11-19 1993-04-06 Oklahoma Medical Research Foundation Recombinant bile salt activated lipases
US5204134A (en) * 1989-01-13 1993-04-20 Immuno Path Profile, Inc. Hypoallergenic milk products from natural and/or synthetic components and process of making
SE9001985D0 (sv) * 1990-06-01 1990-06-01 Astra Ab New chemical products

Also Published As

Publication number Publication date
SK285420B6 (sk) 2007-01-04
SK108595A3 (en) 1997-01-08
AU675701B2 (en) 1997-02-13
HU221119B1 (en) 2002-08-28
EP0687296B1 (en) 2006-02-08
KR100357016B1 (ko) 2002-10-19
CN1187450C (zh) 2005-02-02
ES2258262T3 (es) 2006-08-16
FI954082A7 (fi) 1995-08-31
NO953426D0 (no) 1995-08-31
US5763739A (en) 1998-06-09
DK0687296T3 (da) 2006-06-12
FI954082L (fi) 1995-08-31
BR9406376A (pt) 1996-01-16
ATE317429T1 (de) 2006-02-15
CZ290927B6 (cs) 2002-11-13
US5827683A (en) 1998-10-27
JPH08507439A (ja) 1996-08-13
KR100312825B1 (ko) 2001-12-28
CN1121355A (zh) 1996-04-24
EP0687296A1 (en) 1995-12-20
SG52597A1 (en) 1998-09-28
IS4130A (is) 1994-09-02
PL184960B1 (pl) 2003-01-31
TW387013B (en) 2000-04-11
AU6223794A (en) 1994-09-26
IL108698A0 (en) 1994-05-30
NZ262529A (en) 1997-07-27
WO1994020610A1 (en) 1994-09-15
CA2156083A1 (en) 1994-09-15
PT687296E (pt) 2006-05-31
FI954082A0 (fi) 1995-08-31
CA2156083C (en) 2008-07-15
DE69434622D1 (de) 2006-04-20
HUT73398A (en) 1996-07-29
JP3837444B2 (ja) 2006-10-25
EE9400458A (et) 1996-06-17
RU2219239C2 (ru) 2003-12-20
DE69434622T2 (de) 2006-08-24
CN1346888A (zh) 2002-05-01
CN1071790C (zh) 2001-09-26
HU9502561D0 (en) 1995-10-30
CZ216995A3 (en) 1997-05-14
UA48109C2 (uk) 2002-08-15
PL310413A1 (en) 1995-12-11
IL144015A (en) 2006-08-20

Similar Documents

Publication Publication Date Title
NO953426D0 (no) Varianter av gallesalt-stimulert lipase, DNA molekyler som koder for disse og transgene ikke-humane pattedyr
ATE317904T1 (de) Überexpression von phytase in hefesystemen
HU9300627D0 (en) Transfer protein for microsomal triglycerides
DE69739979D1 (de) Nukleinsäuren, die für Enzyme aus Weizen kodieren, welche an der Stärkesynthese beteiligt sind
DE69316501D1 (de) Proteasen zur Inhibierung und Beseitigung von Biofilm
IS5959A (is) Aðferð til hástigstjáningar virkra lífvessaeiturefnis-ß-þegaónæmisglóbúlínshermiprótína og hreinsunar þeirra
DE59712469D1 (en) Invertase-inhibitor
WO1998005760A3 (en) Phosphate starvation-inducible proteins
FR2681076B1 (fr) Adn recombinant codant pour une proteine a activite endochitinase.
WO1999055883A3 (en) Triacylglycerol lipases
DE60044038D1 (de) Xylosyltransferase und isoformen
ATE239082T1 (de) Dna, welche für eine chitin-synthase aus arthropoden kodiert
WO2001018190A3 (de) Dihydroorotase aus pflanzen
Nguyen et al. Removal of Mn2+ induces dissociation of glutamine synthetase from Streptomyces aureofaciens
WO2002034903A3 (fr) Acide nucleique regulateur du gene abca7, molecules modulant son activite et applications therapeutiques
DK0576899T3 (da) Gen, som koder for et protein med lipaseaktivitet, og fremgangsmåde til fremstilling deraf
AU571559B2 (en) Alpha-allenic-alpha amino acids

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application